References
- Albrechtsen O. K. Fibrinolytic activity in the organism. Acta physiol. scand. 1959; 47: 165, Suppl.
- Alkjaersig N. Human plasminogen, purification, properties and activation. Copenhagen 1965, Thesis
- Biezenski J. J., Moore H. C. Fibrinolysis in normal pregnancy. J. clin. Path. 1958; 11: 306
- Biezenski J. J. Antifibrinolytic activity in normal pregnancy. J. clin. Path. 1960; 13: 220
- Blix S. The proactivator of the fibrinolytic system in human plasma. The quantitative determination and its clinical application. Acta med. scand. 1962; 171: 83
- Blix S. The stability of fibrinolytic inhibitors in human serum and the inhibitor content in animal sera. Scand. J. clin. Lab. Invest. 1964; 16: 614
- Brakman P., Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. clin. Lab. Invest. 1963; 15: 603
- Brakman P. The fibrinolytic system in human blood during pregnancy. Amer. J. Obst. Gynec. 1966; 94: 14
- Buck F. F., Hummel B. C. W., DeRenzo E. C. Interaction of streptokinase and human plasminogen. V. Studies on the nature and mechanism of formation of the enzymatic site of the activator complex. J. biol. Chem. 1968; 243: 3648
- Cope J. Plasmin and plasminogen levels in pregnancy. Austr. New Zeal. J. Obstet Gynaec. 1965; 5: 152
- Eisner P. Fibrinolyse in Schwangerschaft und Geburt. Bibl. Gynaecol. 1957; 16
- Ganrot P. O., Bjerre B. α1-antitrypsin and α2-macroglobulin concentration in serum during pregnancy. Acta obstet. Gynec. Scand. 1967; 46: 126
- Gillman T., Naidoo S. S., Hathorn M. Plasma fibrinolytic activity in pregnancy. Lancet 1959; 11: 70
- Guest M. M. Profibrinolysin. antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject. J. clin. Invest. 1954; 33: 1553
- Hedner U., Nilsson I. M. Determination of plasminogen in human plasma by a casein method. Thromb. Diathès. haemorrh. (Stuttg.) 1965; 14: 545
- Hilden M., Amris C. J., Starup J. The haemostatic mechanism in oral contraception. Acta Obstet. Gynec. Scand. 1967; 46: 562
- Hummel B. C. W., Buck F. F., DeRenzo E. C. Interaction of streptokinase and human plasminogen. III. Plasmin and activator activities in reaction mixtures of streptokinase and human plasminogen or human plasmin of various molar ratios. J. biol. Chem. 1966; 241: 3674
- Kawano T., Morimoto K., Uemura Y. Urokinase inhibitor in human placenta. Nature (Lond.) 1968; 217: 253
- Lassen M. Evidence of the different nature of human plasminogen and proactivator. Acta chem. scand. 1959; 13: 1064
- Lauritsen O. S. Studies on the inhibition of plasmin caseinolysis by human serum and a method for the assay of inhibiting activity. Scand. J. clin. Lab. Invest. 1966; 18: 73
- Lauritsen O. S. Activation of porcine plasminogen by human urokinase. Scand. J. clin. Lab. Invest. 1968; 22: 239
- Lauritsen O. S. Urokinase inhibitor in human plasma. Scand. J. clin. Lab. Invest. 1968; 22: 314
- Lauritsen O. S. Inhibition of plasminogen activation and plasmin activity after euglobulin precipitation and acidification of plasma. Scand. J. clin. Lab. Invest. 1969; 23: 121
- Lauritsen O. S. Studies on proactivator activity in human blood. Scand. J. clin. Lab. Invest. 1969; 23: 129
- Mitchell P., Cope I. The estimation of plasminogen in human serum or plasma. Clin. chim. Acta 1965; 11: 414
- Müllertz S. Mechanism of activation and effect of plasmin in blood. Acta physiol. scand. 1956; 38: 130, Suppl.
- Naidoo S. S., Hathorn M., Gillman T. Fibrinolytic and antifibrinolytic activity in pregnancy. J. clin. Path. 1960; 13: 224
- Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obst. Gynec. Scand. 1967; 46: 273
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
- Philips L. L., Skrodelis V. The fibrinolytic enzyme system in normal, hemorrhagic and disease states. J. clin. Invest. 1958; 37: 965
- Revelli E., Panazzolo A., Scarpa F. The fibrinolytic enzyme system in physiological pregnancies at term and during labour. Panminerva med. 1966; 8: 110
- Rimon S., Stupp Y., Rimon A. Studies on the activation of plasminogen. III. Insoluble derivatives of the proactivator and the activator. Canad. J. Biochem. 1966; 44: 415
- Ruckstuhl L., Bellet S., Sandberg H., Gelber L. Changes in fibrinolytic parameters during the course of normal pregnancy. Am. J. Obstet. Gynec. 1962; 84: 424
- Shaper A. G., Macintoch D. M., Evans C. M., Kyobe J. Fibrinolysis and plasminogen levels in pregnancy and the puerperium. Lancet 1965; II: 706
- Shaper A. G., Macintosh D. M., Kyobe J. Fibrinolytic activity in pregnancy, during parturition, and in the puerperium. Lancet 1966; 11: 874
- Shaper A. G., Kear J., Macintosh D. M., Kyobe J. The platelet count, platelet adhesiveness and aggregation and the mechanism of fibrinolytic inhibition in pregnancy and the puerperium. J. Obstet. Gynaec. Brit. Cwlth. 1968; 75: 433
- Slotta K. H., Gonzales J. D. Native plasminogen. Biochemistry 1964; 3: 285
- Spöttl R. Die Bestimmung des Proaktivators des fibrinolytischen Systems mit einer quantitativen kaseinolytischen Methode. Thromb. Diathes. haemorrh. (Stuttg.) 1967; 18: 393
- Spöttl F., Constantini R. Die Bedeutung des Proactivators im fibrinolytischen Ferment- system. Thromb. Diathes. haemorrh. (Stuttg.) 1967; 18: 416
- Summaria L., Ling C.-M., Groskopf W. R., Robbins K. C. The active site of bovine plasminogen activator. Interaction of streptokinase with human plasminogen and plasmin. J. biol. Chem. 1968; 243: 144
- Uszyñski M., Uszyñska-Folejewska R. Über die fibrinolytische Aktivität des Euglobulins bei intakter Schwangerschaft und missed abortion. Gynaecologia (Basel) 1966; 161: 288